Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
I think you'll find Pfizer have already conducted positive in vitro tests against Omicrom for their pill
https://www.cidrap.umn.edu/news-perspective/2021/12/pfizer-says-its-pill-may-be-effective-against-omicron-covid-19
'Never been wrong' lol
Zwartkops you predicted £50 a share in Aug 20 by Dec 20. You were the resident ramper on this board for 3-6 months spouting all sorts of rubbish.
I ignored you then, think ill do the same again
Great to see the partial recovery today, was there catalyst for this lift?
Yes this is tough to watch but this is a long term investment for me (Doesn't make the slide any easier to digest).
crl123, I've seen that takeover article posted on nearly every aim share I own when they are having a tough month(s) - not sure you can read too much into it.
I disagree, looking at past history of Synairgen interviews and announcements
the company use the expression 'Progressing well' on the Home trial results announcement in October 2020, we were then waiting for several months.
Synairgen use the word 'Imminently' when referring to the COPD results and P3 Sprinter FPD results from which we were waiting for 3 - 4 weeks before RNS announcements.
So to my mind after reading 'Progressing Well' I'm not expecting an LPD for Sprinter in the next 4 weeks, as based on previous announcements they would otherwise be using the word 'imminently'.
This is of course my own conjecture.
I disagree with you both there,
In October 2020 during a published online proactive interview with RM and pre-fundraising, RM stated the company's 'Aim' was to complete the P3 Sprinter trial by MARCH 2021.
Then when the trial dates where published we found out estimated completion was September 2021
Then the official delay occurred stating estimated completion October 2021
Now other sources claim estimated completion November 2021